BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pacira Pharmaceuticals, Inc. 

10450 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-625-2414 Fax: 858-678-3999


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Pacira Pharmaceuticals, Inc. (PCRX) Announces Timing For Second Quarter 2014 Financial Results Webcast And Conference Call 7/17/2014 12:01:14 PM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Publication Of Pooled Results From IMPROVE Studies Evaluating Health Economic Benefits Of EXPAREL® 6/26/2014 10:13:24 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces sNDA Submission For EXPAREL Nerve Block Indication 5/7/2014 8:44:43 AM
Pacira Pharmaceuticals, Inc. (PCRX) To Present At The Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/6/2014 7:07:53 AM
Pacira Pharmaceuticals, Inc. (PCRX) Reports First Quarter EXPAREL Revenue Of $34.4 Million And First Quarter 2014 Results 5/1/2014 2:50:02 PM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Timing For First Quarter 2014 Financial Results Webcast And Conference Call 4/17/2014 6:52:48 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Grants Of Inducement Stock Options Under NASDAQ Listing Rule 5635(c)(4) 4/16/2014 9:31:19 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Proposed Public Offering Of Common Stock 4/8/2014 9:37:00 AM
Pacira Pharmaceuticals, Inc. (PCRX) Release: Exparel Use In Femoral Nerve Block For Total Knee Arthroplasty Further Supported By Additional Data From Phase 3 Pivotal Study, SNDA Submission Planned For Second Quarter 2014 4/7/2014 9:35:27 AM
Pacira Pharmaceuticals, Inc. (PCRX) Release: Two New Studies Support Use Of EXPAREL For Postsurgical Pain Management Following Total Joint Replacement 3/14/2014 1:30:16 PM
12345678910...